Literature DB >> 24791346

The efficacy of permethrin 5% vs. oral ivermectin for the treatment of scabies.

Mohammad Reza Ranjkesh, Behrouz Naghili, Mohamad Goldust, Elham Rezaee.   

Abstract

Human scabies is caused by an infestation of the skin by the human itch mite (Sarcoptes scabiei var. hominis). The aim of this study is to compare the efficacy and safety of permethrin 5% lotion with oral ivermectin for the treatment of scabies. In total, 60 patients with scabies were enrolled, and randomized into two groups: The first group and their family contacts received 5% permethrin cream twice with a one week interval, and the other received a single dose of oral ivermectin. Treatment was evaluated at intervals of 2 and 4 weeks. A single dose of ivermectin provided a cure rate of 62.4%, which increased to 92.8% with 2 doses at a 2-week interval. Treatment with two applications of permethrin with a one week interval was effective in 96.9% of patients. Permethrin-treated patients recovered earlier. Two applications of permethrin with a one week interval is more effective than a single dose of ivermectin. Two doses of ivermectin is as effective as a single application of permethrin.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24791346

Source DB:  PubMed          Journal:  Ann Parasitol        ISSN: 2299-0631


  9 in total

Review 1.  The Treatment of Scabies.

Authors:  Corinna Dressler; Stefanie Rosumeck; Cord Sunderkötter; Ricardo Niklas Werner; Alexander Nast
Journal:  Dtsch Arztebl Int       Date:  2016-11-14       Impact factor: 5.594

2.  Scabies in residential care homes: Modelling, inference and interventions for well-connected population sub-units.

Authors:  Timothy Kinyanjui; Jo Middleton; Stefan Güttel; Jackie Cassell; Joshua Ross; Thomas House
Journal:  PLoS Comput Biol       Date:  2018-03-26       Impact factor: 4.475

3.  The effect of subacute poisoning with fenpropathrin on mice kidney function and the level of interleukin 1β and tumor necrosis factor α.

Authors:  Maria Jaremek; Barbara Nieradko-Iwanicka
Journal:  Mol Biol Rep       Date:  2020-05-08       Impact factor: 2.316

4.  Treatment, prevention and public health management of impetigo, scabies, crusted scabies and fungal skin infections in endemic populations: a systematic review.

Authors:  Philippa J May; Steven Y C Tong; Andrew C Steer; Bart J Currie; Ross M Andrews; Jonathan R Carapetis; Asha C Bowen
Journal:  Trop Med Int Health       Date:  2019-01-28       Impact factor: 2.622

Review 5.  Crusted Scabies, a Neglected Tropical Disease: Case Series and Literature Review.

Authors:  Nurdjannah Jane Niode; Aryani Adji; Shienty Gazpers; Renate Tamara Kandou; Herry Pandaleke; Dwi Martina Trisnowati; Christy Tumbelaka; Elrovita Donata; Fauziyyah Nurani Djaafara; Hendrix Indra Kusuma; Ali A Rabaan; Mohammed Garout; Souad A Almuthree; Hatem M Alhani; Mohammed Aljeldah; Hawra Albayat; Mohammed Alsaeed; Wadha A Alfouzan; Firzan Nainu; Kuldeep Dhama; Harapan Harapan; Trina Ekawati Tallei
Journal:  Infect Dis Rep       Date:  2022-06-16

Review 6.  Ivermectin and permethrin for treating scabies.

Authors:  Stefanie Rosumeck; Alexander Nast; Corinna Dressler
Journal:  Cochrane Database Syst Rev       Date:  2018-04-02

7.  Comparative Efficacy of Topical Pertmehrin, Crotamiton and Sulfur Ointment in Treatment of Scabies.

Authors:  Celestyna Mila-Kierzenkowska; Alina Woźniak; Ewa Krzyżyńska-Malinowska; Lucyna Kałużna; Roland Wesołowski; Wojciech Poćwiardowski; Marcin Owcarz
Journal:  J Arthropod Borne Dis       Date:  2017-03-14       Impact factor: 1.198

Review 8.  Current Research on the Safety of Pyrethroids Used as Insecticides.

Authors:  Agnieszka Chrustek; Iga Hołyńska-Iwan; Inga Dziembowska; Joanna Bogusiewicz; Marcin Wróblewski; Anna Cwynar; Dorota Olszewska-Słonina
Journal:  Medicina (Kaunas)       Date:  2018-08-28       Impact factor: 2.430

Review 9.  Pyrethroids: How They Affect Human and Animal Health?

Authors:  Iga Hołyńska-Iwan; Karolina Szewczyk-Golec
Journal:  Medicina (Kaunas)       Date:  2020-10-30       Impact factor: 2.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.